Q2
DRMA — Q2 2026 Financial Report Analysis
Dermata's net loss widened 74% to $2.97M as pre-launch marketing and legal costs more than doubled SG&A ahead of its Tome skincare debut; with no revenue and $4.4M cash at June 30 it raised another ~$3.2M in August.